These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38871359)

  • 21. Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction.
    Tazi-Ahnini R; Cox A; McDonagh AJ; Nicklin MJ; di Giovine FS; Timms JM; Messenger AG; Dimitropoulou P; Duff GW; Cork MJ
    Eur J Immunogenet; 2002 Feb; 29(1):25-30. PubMed ID: 11841485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-Environment Interaction between the
    Shao Y; Zhang Y; Liu M; Fernandez-Beros ME; Qian M; Reibman J
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32204425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in interleukin-1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: a case-control study.
    Lee JM; Kang YR; Park SH; Cha SI; Kim JS; Kang HK; Lee WK; Kim MJ; Kim CH; Kim NS; Jung TH; Park JY
    Respir Med; 2008 Sep; 102(9):1311-20. PubMed ID: 18579366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes.
    Luotola K; Pietilä A; Alanne M; Lanki T; Loo BM; Jula A; Perola M; Peters A; Zeller T; Blankenberg S; Salomaa V;
    Metabolism; 2010 Oct; 59(10):1520-7. PubMed ID: 20178882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 Alpha Polymorphisms Are Associated With Body Mass Index in Male But Not in Female Adolescents.
    Mendoza-Carrera F; Ramírez-López G; Hernández-Ramos LE; Leal-Cortés C; Portilla-de-Buen E; Castro-Martínez XH; Castro Martínez AG; López-Quintero A; Flores-Martínez SE; Sánchez-Corona J
    Arch Med Res; 2019 Apr; 50(3):151-157. PubMed ID: 31495392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.
    Smith AJ; Keen LJ; Billingham MJ; Perry MJ; Elson CJ; Kirwan JR; Sims JE; Doherty M; Spector TD; Bidwell JL
    Genes Immun; 2004 Sep; 5(6):451-60. PubMed ID: 15190266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
    Shu KH; Lee SH; Cheng CH; Wu MJ; Lian JD
    Kidney Int; 2000 Aug; 58(2):783-9. PubMed ID: 10916103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of Māori and Pacific ancestry.
    Azevedo PM; Merriman TR; Topless RK; Wilson NJ; Crengle S; Lennon DR
    Cytokine; 2016 Sep; 85():201-6. PubMed ID: 27400406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome.
    Witkin SS; Vardhana S; Yih M; Doh K; Bongiovanni AM; Gerber S
    Am J Obstet Gynecol; 2003 Nov; 189(5):1413-7. PubMed ID: 14634579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A polymorphism in the IL1B gene (rs16944 T/C) is associated with cutaneous leishmaniasis caused by Leishmania guyanensis and plasma cytokine interleukin receptor antagonist.
    da Silva GAV; de Mesquita TGR; de Souza Encarnação HV; do Espírito Santo Junior J; da Costa Sabino K; de Aguiar Neres I; de Almeida SA; de Souza MLG; Talhari S; Ramasawmy R
    Cytokine; 2019 Nov; 123():154788. PubMed ID: 31357078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis.
    Hinze C; Fuehner S; Kessel C; Wittkowski H; Lainka E; Baehr M; Hügle B; Haas JP; Ganser G; Weißbarth-Riedel E; Jansson A; Foell D
    Arthritis Rheumatol; 2020 Mar; 72(3):499-505. PubMed ID: 31599092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure.
    Dahmer MK; Quasney MW; Sapru A; Gildengorin G; Curley MAQ; Matthay MA; Flori H;
    Pediatr Crit Care Med; 2018 Oct; 19(10):930-938. PubMed ID: 30095747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the relationship between IL17A, IL17F and ILR1N polymorphisms and COVID-19 severity: The predictive role of IL17A rs2275913 polymorphism in the clinical course of COVID-19.
    Cakmak Genc G; Karakas Celik S; Yilmaz B; Piskin N; Altinsoy B; Dursun A
    Int J Immunogenet; 2023 Jun; 50(3):117-126. PubMed ID: 37052545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 1 receptor antagonist (IL1RN) genetic variations condition post-orthodontic external root resorption in endodontically-treated teeth.
    Iglesias-Linares A; Yañez-Vico RM; Ballesta-Mudarra S; Ortiz-Ariza E; Mendoza-Mendoza A; Perea-Pérez E; Moreno-Fernández AM; Solano-Reina E
    Histol Histopathol; 2013 Jun; 28(6):767-73. PubMed ID: 23212299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.
    Price CC; Altice FL; Shyr Y; Koff A; Pischel L; Goshua G; Azar MM; Mcmanus D; Chen SC; Gleeson SE; Britto CJ; Azmy V; Kaman K; Gaston DC; Davis M; Burrello T; Harris Z; Villanueva MS; Aoun-Barakat L; Kang I; Seropian S; Chupp G; Bucala R; Kaminski N; Lee AI; LoRusso PM; Topal JE; Dela Cruz C; Malinis M
    Chest; 2020 Oct; 158(4):1397-1408. PubMed ID: 32553536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease.
    Fontanini E; Cussigh A; Fabris C; Falleti E; Toniutto P; Bitetto D; Cmet S; Fumolo E; Fornasiere E; Bignulin S; Pinato DJ; Minisini R; Pirisi M
    Inflammation; 2010 Aug; 33(4):251-8. PubMed ID: 20087638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.
    Vamvakopoulos J; Green C; Metcalfe S
    Eur J Immunol; 2002 Oct; 32(10):2988-96. PubMed ID: 12355453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IL1RN promoter rs4251961 correlates with IL-1 receptor antagonist concentrations in human infection and is differentially regulated by GATA-1.
    Carrol ED; Payton A; Payne D; Miyajima F; Chaponda M; Mankhambo LA; Banda DL; Molyneux EM; Cox H; Jacobson G; Carr DF; Molyneux ME; Stewart JP; Quinn JP; Hart CA; Ollier WE
    J Immunol; 2011 Feb; 186(4):2329-35. PubMed ID: 21248262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans.
    Pihlajamäki J; Kuulasmaa T; Kaminska D; Simonen M; Kärjä V; Grönlund S; Käkelä P; Pääkkönen M; Kainulainen S; Punnonen K; Kuusisto J; Gylling H; Laakso M
    J Hepatol; 2012 Mar; 56(3):663-70. PubMed ID: 22027586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 Receptor Antagonist Polymorphism and Birth Timing: Pathway Analysis Among African American Women.
    Gillespie SL; Neal JL; Christian LM; Szalacha LA; McCarthy DO; Salsberry PJ
    Nurs Res; 2017; 66(2):95-104. PubMed ID: 28252571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.